Why the study?
Does cardiac troponin measurement predict adverse outcomes in patients with cardiovascular diseases other than acute coronary syndrome?
Does cardiac troponin measurement predict adverse outcomes in patients with cardiovascular diseases other than acute coronary syndrome?
Elevated cardiac troponin in non-ACS patients indicates higher risk for adverse outcomes and should prompt investigation and management of underlying conditions.
No takes yet. Share an insight, caveat, or question.
Elevated troponin flags higher risk in non-ACS cardiovascular disease; leaves open whether routine measurement should guide management.
Eggers et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: